CEO's On the Move
Constantine Iordanou to Transition from Chief Executive Officer of Arch Capital Group Ltd., Effective March 2, 2018
Arch Capital Group Ltd.
:NASDAQ) Pursuant to a Service Agreement dated September 21, 2017, commencing March 2, 2018 Mr. Constantine Iordanou will transition from Chief Executive Officer of Arch Capital Group Ltd. and will remain as a member of company's Board of Directors and will serve as non-executive Chairman of the Board.
Upcoming Board Meetings
September 23, 2017
Man Sang International Limited, Board Meeting, Sep 23, 2017. Agenda: To consider and approving the final results of the company and its subsidiaries for the year ended 31 March 2017 and its publication; and to consider the payment of dividend, if applicable.
Man Sang International Limited Key Board Members
Group Chief Financial Officer, Company Secretary and Executive Director
Garodia Chemicals Limited Appoints Trupti Madhukar Bolke as Independent Director
Garodia Chemicals Limited in its AGM to be held on September 30, 2017 appointed Ms. Trupti Madhukar Bolke as an Independent Director, who was appointed as Additional Independent Director in the meeting of Board of Directors held on February 13, 2017.
Mukuba Resources Limited and ANM, Inc. Announce Management Appointments for Resulting Issuer
Mukuba Resources Limited ("Mukuba" or the "company") and ANM, Inc. ("ANM") (doing business as Halo Labs) announced that they have entered into a binding letter of INTENT ("LOI") to complete a business combination transaction (the "Transaction"). Upon completion of the transaction, the combined entity (the "Resulting Issuer") will continue to carry on the business of ANM. The Transaction is expected to be completed by way of a triangular merger between ANM, Mukuba and a wholly-owned subsidiary of Mukuba to be incorporated under the laws of Delaware, pursuant to which all of the issued and outstanding common shares of ANM will be converted into Resulting Issuer Shares on the basis of 1.10602 Resulting Issuer Share for each ANM Share. A meeting of Mukuba shareholders will be held prior to the closing of the Transaction to obtain shareholder approval for: (i) the Mukuba Consolidation; (ii) the Transaction; (iii) the listing of the Resulting Issuer Shares on the Exchange; (iv) the concurrent delisting of the Mukuba Shares from the TSXV; and (v) the changing of the name of Mukuba to Halo Labs Inc. Mukuba will also seek approval for 6 new board members of Mukuba ("New Board Members") who will replace the existing board members and be the directors of the Resulting Issuer upon the closing of the Transaction. The proposed New Board Members are expected to be: Kiran Sidhu, Chief Executive Officer and Director: Kiran Sidhu is the Chief Executive Officer of ANM. Mr. Sidhu was a manager with Pricewaterhouse Cooper's strategic consulting group in Los Angeles and a senior associate with Merrill Lynch Capital Markets in mergers and acquisitions in New York. Mr. Sidhu served as CFO of On Stage Entertainment. Mr. Sidhu is currently a director of Namaste Technologies Inc. Upon completion of the Transaction, Mr. Sidhu will be appointed Chief Executive Officer of the Resulting Issuer. Fred Leigh, Director: Fred Leigh has over 35 years of experience in the junior resource sector including founding Siwash Holdings Ltd. Mr. Leigh is currently the chairman of QMX Gold Corporation and the president of Routemaster Capital Inc. Andreas Met, Chief Marketing Officer and Director: Andreas Met is the Chief Marketing Officer of ANM. Mr. Met was a Senior Merchant at Walmart where he managed the Household Chemicals desk. Prior to joining ANM, Mr. Met was the head of sales and marketing at Golden Leaf Holdings Ltd. Gilbert Sharp, Director: Mr. Sharp has over 40 years of legal experience including roles as a partner in prominent Toronto law firms, the Director of the Legal Branch of the Ontario Ministry of Health (General Counsel) and a professor in the Faculty of Law at the University of Toronto. Mr. Sharp has also acted as a special adviser on healthcare projects for the World Bank, Inter-American Bank, and the World Health Organization. J. Francisco Turner, Director: Mr. Turner has over 20 years of experience as a finance and investment professional, including roles as the president and chief financial officer of Banc of California and managing director of Bancorp Bank. Philip van den Berg, Director: Mr. van den Berg is currently the Chief Financial Officer of Namaste.
Pediapharm Inc. Announces Directorate Changes
Pediapharm Inc. announced at the AGM held on September 22, 2017, Mr. Pierre Desormeau did not stand for re-election as a director of the company to pursue other matters. Mr. Benoit Gravel was elected to the Board for the first time. Benoit Gravel began his career as an economist in the Energy and Transportation industries in Canada with Hydro-Quebec and VIA Rail. He joined the pharmaceutical industry 30 years ago at Rhone-Poulenc in Montreal as Director, Corporate Planning & Business Development. He spent 3 years in Paris in Global Business Development and returned to Canada as Vice-President, External Affairs, Vice-President Finance and President. At the creation of Aventis he was appointed Vice-President, Commercial Affairs. His last assignment with Sanofi before retirement was Vice-President, Global Portfolio Management & Strategic Development based in Prague, Czech Republic in the Global Generics division.